• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化癌细胞膜:一种用于高效癌症诊疗的新兴制剂。

Engineered cancer cell membranes: An emerging agent for efficient cancer theranostics.

作者信息

Guo Yunqi, Wang Zhiqiang, Shi Xiangyang, Shen Mingwu

机构信息

Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Chemistry, Chemical Engineering and Biotechnology Donghua University Shanghai P. R. China.

出版信息

Exploration (Beijing). 2022 Jan 25;2(1):20210171. doi: 10.1002/EXP.20210171. eCollection 2022 Feb.

DOI:10.1002/EXP.20210171
PMID:37324583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10190949/
Abstract

For efficient cancer theranostics, surface modification of nanomaterials plays an important role in improving targeting ability and reducing the non-specific interactions with normal tissues. Recently, the biomimetic technology represented by coating of cancer cell membranes (CCMs) has been regarded as a promising method to strengthen the biocompatibility and targeting specificity of nanomaterials. Furthermore, the engineered CCMs (ECCMs) integrated with the natural biological properties of CCMs and specific functions from other cells or proteins have offered more possibilities in the field of cancer theranostics. Herein, the recent progresses in the design and preparation of ECCMs are summarized, and the applications of ECCMs in targeting delivery, activation of immunity, and detection of circulating tumor cells are reviewed. Finally, the current challenges and future perspectives with regard to the development of ECCMs are briefly discussed.

摘要

对于高效的癌症诊疗,纳米材料的表面修饰在提高靶向能力和减少与正常组织的非特异性相互作用方面起着重要作用。近年来,以癌细胞膜(CCM)包覆为代表的仿生技术被认为是增强纳米材料生物相容性和靶向特异性的一种有前景的方法。此外,将CCM的天然生物学特性与其他细胞或蛋白质的特定功能相结合的工程化癌细胞膜(ECCM)在癌症诊疗领域提供了更多可能性。在此,总结了ECCM设计与制备的最新进展,并综述了ECCM在靶向递送、免疫激活和循环肿瘤细胞检测中的应用。最后,简要讨论了ECCM发展目前面临的挑战和未来前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924e/10190949/f6129db8663c/EXP2-2-20210171-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924e/10190949/e194ba4d9bd6/EXP2-2-20210171-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924e/10190949/07c6ebe7017e/EXP2-2-20210171-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924e/10190949/167085bef97a/EXP2-2-20210171-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924e/10190949/21a8ffa3a718/EXP2-2-20210171-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924e/10190949/12ed3e5b5fb9/EXP2-2-20210171-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924e/10190949/f6129db8663c/EXP2-2-20210171-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924e/10190949/e194ba4d9bd6/EXP2-2-20210171-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924e/10190949/07c6ebe7017e/EXP2-2-20210171-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924e/10190949/167085bef97a/EXP2-2-20210171-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924e/10190949/21a8ffa3a718/EXP2-2-20210171-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924e/10190949/12ed3e5b5fb9/EXP2-2-20210171-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924e/10190949/f6129db8663c/EXP2-2-20210171-g009.jpg

相似文献

1
Engineered cancer cell membranes: An emerging agent for efficient cancer theranostics.工程化癌细胞膜:一种用于高效癌症诊疗的新兴制剂。
Exploration (Beijing). 2022 Jan 25;2(1):20210171. doi: 10.1002/EXP.20210171. eCollection 2022 Feb.
2
Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.干细胞膜、干细胞衍生的外泌体和杂交干细胞伪装纳米颗粒:一种有前途的仿生纳米平台,用于癌症治疗和诊断。
J Control Release. 2022 Aug;348:706-722. doi: 10.1016/j.jconrel.2022.06.026. Epub 2022 Jun 22.
3
Biomimetic Cell Membrane-Coated Nanoparticles for Cancer Theranostics.仿生细胞膜包覆的纳米粒子用于癌症治疗与诊断。
ChemMedChem. 2024 Nov 18;19(22):e202400410. doi: 10.1002/cmdc.202400410. Epub 2024 Sep 12.
4
Recent advances in biological membrane-based nanomaterials for cancer therapy.生物膜基纳米材料在癌症治疗中的最新进展。
Biomater Sci. 2022 Oct 11;10(20):5756-5785. doi: 10.1039/d2bm01044e.
5
Research update on cell membrane camouflaged nanoparticles for cancer therapy.用于癌症治疗的细胞膜伪装纳米颗粒的研究进展
Front Bioeng Biotechnol. 2022 Aug 5;10:944518. doi: 10.3389/fbioe.2022.944518. eCollection 2022.
6
Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.混合细胞膜包覆纳米颗粒:用于癌症诊断与治疗的多功能仿生平台。
Acta Biomater. 2020 Aug;112:1-13. doi: 10.1016/j.actbio.2020.05.028. Epub 2020 May 26.
7
Hybrid Membrane-Coated Biomimetic Nanoparticles (HM@BNPs): A Multifunctional Nanomaterial for Biomedical Applications.杂化膜包覆仿生纳米粒子 (HM@BNPs):一种用于生物医学应用的多功能纳米材料。
Biomacromolecules. 2021 Aug 9;22(8):3149-3167. doi: 10.1021/acs.biomac.1c00440. Epub 2021 Jul 6.
8
Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics.用于癌症诊疗的仿生纳米材料引发铁死亡
Front Chem. 2021 Nov 16;9:768248. doi: 10.3389/fchem.2021.768248. eCollection 2021.
9
Engineered Cell Membrane-Derived Nanocarriers: The Enhanced Delivery System for Therapeutic Applications.工程化细胞膜衍生纳米载体:用于治疗应用的增强递送系统。
Front Cell Dev Biol. 2022 Feb 28;10:844050. doi: 10.3389/fcell.2022.844050. eCollection 2022.
10
Choice of Nanoparticles for Theranostics Engineering: Surface Coating to Nanovalves Approach.用于治疗学工程的纳米粒子选择:从表面涂层到纳米阀方法。
Nanotheranostics. 2024 Jan 1;8(1):12-32. doi: 10.7150/ntno.89768. eCollection 2024.

引用本文的文献

1
Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives.用于疫苗开发的生物工程外膜囊泡:策略、进展与展望
Vaccines (Basel). 2025 Jul 20;13(7):767. doi: 10.3390/vaccines13070767.
2
Biomembrane-coated nanosystems as next-generation delivery systems for the treatment of gastrointestinal cancers.生物膜包被的纳米系统作为治疗胃肠道癌症的下一代递送系统。
Bioeng Transl Med. 2025 Feb 26;10(4):e70006. doi: 10.1002/btm2.70006. eCollection 2025 Jul.
3
Janus Ag/Fe-HfO nanoparticles for enhanced radio-photothermal tumor therapy via magnetic resonance imaging and multienzyme activity.

本文引用的文献

1
Multifunctional Core-Shell Tecto Dendrimers Incorporated with Gold Nanoparticles for Targeted Dual Mode CT/MR Imaging of Tumors.多功能核壳树枝状大分子与金纳米粒子的结合用于肿瘤的靶向双模 CT/MR 成像。
ACS Appl Bio Mater. 2021 Feb 15;4(2):1803-1812. doi: 10.1021/acsabm.0c01525. Epub 2021 Jan 18.
2
Hybrid Membrane-Coated Biomimetic Nanoparticles (HM@BNPs): A Multifunctional Nanomaterial for Biomedical Applications.杂化膜包覆仿生纳米粒子 (HM@BNPs):一种用于生物医学应用的多功能纳米材料。
Biomacromolecules. 2021 Aug 9;22(8):3149-3167. doi: 10.1021/acs.biomac.1c00440. Epub 2021 Jul 6.
3
Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications.
用于通过磁共振成像和多酶活性增强放射光热肿瘤治疗的Janus银/铁-氧化铪纳米颗粒
Mater Today Bio. 2025 Jul 11;33:102083. doi: 10.1016/j.mtbio.2025.102083. eCollection 2025 Aug.
4
Bio-barrier-adaptable biomimetic nanomedicines combined with ultrasound for enhanced cancer therapy.生物屏障适应性仿生纳米药物联合超声用于增强癌症治疗
Signal Transduct Target Ther. 2025 Apr 25;10(1):137. doi: 10.1038/s41392-025-02217-8.
5
The role of manganese-based MRI contrast agents for cancer theranostics: Where do we stand in 2025?锰基磁共振成像造影剂在癌症诊疗中的作用:到2025年我们处于什么水平?
Theranostics. 2025 Mar 15;15(9):4147-4174. doi: 10.7150/thno.108705. eCollection 2025.
6
Janus-Structured Micro/Nanomotors: Self-Propelled Mechanisms and Biomedical Applications.双面结构微纳马达:自推进机制及生物医学应用
Biomater Res. 2025 Apr 5;29:0155. doi: 10.34133/bmr.0155. eCollection 2025.
7
Metal-phenolic networks specifically eliminate hypoxic tumors by instigating oxidative and proteotoxic stresses.金属-酚醛网络通过引发氧化应激和蛋白毒性应激特异性地消除缺氧肿瘤。
Bioact Mater. 2025 Feb 12;47:361-377. doi: 10.1016/j.bioactmat.2025.01.022. eCollection 2025 May.
8
Induction of the p21/CDK6 pathway and alteration of the immune microenvironment by the stem cell marker CBX3 in melanoma.干细胞标志物CBX3在黑色素瘤中诱导p21/CDK6通路并改变免疫微环境。
Stem Cell Res Ther. 2025 Feb 11;16(1):63. doi: 10.1186/s13287-025-04179-8.
9
Cancer theragnostics: closing the loop for advanced personalized cancer treatment through the platform integration of therapeutics and diagnostics.癌症治疗诊断学:通过治疗与诊断的平台整合,为先进的个性化癌症治疗闭环。
Front Bioeng Biotechnol. 2025 Jan 17;12:1499474. doi: 10.3389/fbioe.2024.1499474. eCollection 2024.
10
Recent development of micro-nano carriers for oral antineoplastic drug delivery.用于口服抗肿瘤药物递送的微纳米载体的最新进展。
Mater Today Bio. 2025 Jan 3;30:101445. doi: 10.1016/j.mtbio.2025.101445. eCollection 2025 Feb.
细胞膜包被技术:生物医学应用的一种有前景的策略。
Nanomicro Lett. 2019 Nov 16;11(1):100. doi: 10.1007/s40820-019-0330-9.
4
Development of Effective Tumor Vaccine Strategies Based on Immune Response Cascade Reactions.基于免疫反应级联反应的有效肿瘤疫苗策略的发展。
Adv Healthc Mater. 2021 Jul;10(13):e2100299. doi: 10.1002/adhm.202100299. Epub 2021 May 22.
5
Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression.多发性骨髓瘤中的免疫系统改变:逆转免疫抑制的分子机制与治疗策略
Cancers (Basel). 2021 Mar 17;13(6):1353. doi: 10.3390/cancers13061353.
6
Hybrid-cell membrane-coated nanocomplex-loaded chikusetsusaponin IVa methyl ester for a combinational therapy against breast cancer assisted by Ce6.负载杂化细胞膜包覆纳米复合物的七叶皂苷 IVa 甲酯用于在 Ce6 辅助下的乳腺癌联合治疗
Biomater Sci. 2021 Apr 21;9(8):2991-3004. doi: 10.1039/d0bm02211j. Epub 2021 Mar 2.
7
Cell primitive-based biomimetic functional materials for enhanced cancer therapy.基于细胞原代的仿生功能材料用于增强癌症治疗。
Chem Soc Rev. 2021 Jan 21;50(2):945-985. doi: 10.1039/d0cs00152j. Epub 2020 Nov 23.
8
Ultrasound-enhanced fluorescence imaging and chemotherapy of multidrug-resistant tumors using multifunctional dendrimer/carbon dot nanohybrids.使用多功能树枝状大分子/碳点纳米杂化物对多药耐药肿瘤进行超声增强荧光成像和化疗
Bioact Mater. 2020 Sep 24;6(3):729-739. doi: 10.1016/j.bioactmat.2020.09.015. eCollection 2021 Mar.
9
Cancer Cell-Erythrocyte Hybrid Membrane Coated Gold Nanocages for Near Infrared Light-Activated Photothermal/Radio/Chemotherapy of Breast Cancer.癌细胞-红细胞杂合膜包覆金纳米笼用于近红外光激活的乳腺癌光热/放疗/化疗。
Int J Nanomedicine. 2020 Sep 11;15:6749-6760. doi: 10.2147/IJN.S266405. eCollection 2020.
10
Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy.血小板膜功能化纳米颗粒,可提高靶向能力,降低溶栓治疗的出血风险。
J Control Release. 2020 Dec 10;328:78-86. doi: 10.1016/j.jconrel.2020.08.030. Epub 2020 Aug 25.